Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

NCT01172691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplant

Interventions

DRUG: Inhaled Nitric Oxide (iNO)
DRUG: Placebo Arm (Nitrogen)

Sponsor

Baylor Research Institute

Collaborators

[object Object]